J&amp;J to diversify with $24B deal for heart device firm
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
462708
Health care and consumer products maker Johnson &amp; Johnson is close to finalizing its long-rumored $24 billion cash and stock acquisition of medical-device maker Guidant Corp.
253167
Johnson &amp; Johnson is in advanced talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing executives whom the newspaper didn&#39;t name.
32462
Johnson &amp; Johnson, the US medical and consumer goods group, is in advanced discussions to buy Guidant, a maker of medical devices, in a deal that could be worth about $24bn (Â£12bn).
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
711716
Acute care hospital operator Select  Medical Corp. SEM.N said on Monday it is being bought out by  a private equity group for $2.3 billion, sending shares soaring  by 24 percent.
574355
Warner Chilcott, the speciality women's healthcare group, said that it had agreed to a 1.62-billion-pound takeover bid from private equity funds run by JP Morgan and Credit Suisse First Boston.
155569
In negotiating to buy Guidant, Johnson & Johnson is looking for an acquisition to increase its presence in the lucrative, fast-growing market for medical devices.
225711
Johnson &amp; Johnson has made dozens of mostly small acquisitions over the last decade, expanding its portfolio of more than 200 businesses that make products like Band-Aids, artificial knees and blockbuster drugs.
21679
The anticipated merger of Guidant Corp.  and Johnson & Johnson could give an unintended boost to Boston  Scientific Corp. if Guidant's drug-coated stent launch is  delayed, said analysts looking at the implications of a  potential deal.
91019
Johnson &amp; Johnson, the pharmaceutical and health care giant, has announced an agreement to buy Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, for $25.4 billion.
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.
82240
The knee and ankle brace maker said it agreed to be bought by the medical device maker ReAble Therapeutics for about $1.6 billion including debt.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
197805
Johnson &amp; Johnson, the world&#39;s biggest producer of medical devices, is in talks to buy heart defibrillator maker Guidant Corp.
753590
ReAble Therapeutics, the orthopedic-device maker controlled by the private equity company Blackstone Group, agreed to purchase DJO for $1.6 billion.
605466
Johnson &amp; Johnson last night struck a deal to acquire Guidant, the US cardiac treatment group for $25.4bn, in a move that will give it access to one of the fastest growing areas in health care.